Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.06 USD | -0.15% | +7.48% | +51.98% |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 60 | 31/10/20 |
Adam Levy
DFI | Director of Finance/CFO | 46 | 28/02/22 |
Jessica Ibbitson
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/21 |
David Rodman
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/12/20 |
Minji Kim
PRN | Corporate Officer/Principal | - | 01-03 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 31/01/21 | |
Glenn Sblendorio
BRD | Director/Board Member | 68 | 12/09/23 |
Daphne Karydas
BRD | Director/Board Member | 49 | 12/09/23 |
Olivier Litzka
BRD | Director/Board Member | 56 | 07/05/22 |
Jon Congleton
CEO | Chief Executive Officer | 60 | 31/10/20 |
Derek DiRocco
BRD | Director/Board Member | 43 | 07/05/22 |
BT Slingsby
FOU | Founder | 47 | 30/05/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,648,540 | 43,426,364 ( 87.47 %) | 0 | 87.47 % |
Company contact information
Mineralys Therapeutics, Inc.
150 North Radnor Chester Road Suite F200
19087, Radnor
+
http://www.mineralystx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.98% | 649M | |
+45.65% | 56.65B | |
-6.98% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.52% | 26.75B | |
-21.15% | 19.03B | |
+0.92% | 12.28B | |
+24.60% | 12.26B | |
+26.90% | 12.04B |
- Stock Market
- Equities
- MLYS Stock
- Company Mineralys Therapeutics, Inc.